Intestinal Failure-Associated Liver Disease in Neonates

Neoreviews. 2020 Sep;21(9):e591-e599. doi: 10.1542/neo.21-9-e591.

Abstract

Intestinal failure-associated liver disease (IFALD) is common in neonates who suffer from intestinal failure and rely on parenteral nutrition. The etiology is multifactorial, relating to the infant's underlying cause of intestinal failure and other infant factors such as prematurity. Management of the disease includes transitioning to enteral feedings as soon as is safe for the infant. In infants who continue to rely on parenteral nutrition, alternative lipid emulsions and other medications may be used. This article reviews the epidemiology and factors that contribute to IFALD in neonates, in addition to management strategies.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Enteral Nutrition
  • Humans
  • Infant, Newborn
  • Intestinal Diseases* / complications
  • Intestinal Diseases* / epidemiology
  • Intestinal Diseases* / therapy
  • Intestines
  • Liver Diseases* / epidemiology
  • Liver Diseases* / etiology
  • Liver Diseases* / therapy
  • Parenteral Nutrition / adverse effects